The rate of tumor growth during treatment accurately predicts the FDA gold standard of overall survival [OS] in a broad range of malignancies.

2545Background: Novel clinical trial endpoints that predict overall survival (OS) are needed to streamline anticancer drug development. Methods: We used a novel mathematical approach to estimate si...